Cancer immunotherapy has indeed revolutionized anti-cancer drugs, and IL-2 is a key immunotherapeutic agent used to stimulate the immune system to attack cancer cells (Farkona et al., 2016; Zhao et al., 2019; Zhang and Zhang, 2020). This evidence concerns the gene IL2 and cancer.